When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVUS - Novus Therapeutics down big on failed ear infection study
Novus Therapeutics Inc.
Nano cap Novus Therapeutics (NVUS-47.2%) craters on a 13x surge in volume in reaction to unsuccessful results from a Phase 2a clinical trial evaluating intranasal OP0201 as an adjunct to antibiotic therapy in patients with acute otitis media (eye infection).
More news on: Novus Therapeutics, Inc., Healthcare stocks news, Stocks on the move,